The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 9: 1327 - 1331

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.09.008

Basic Research

Expression of TRM cells in the lesions of imiquimod⁃induced models of psoriasis in mice

  • Yuchan ZHOU ,
  • Rongchang ZHENG ,
  • Huarun LI ,
  • Jinping HUANG ,
  • Si QIN ,
  • Ting LI ,
  • Zhenyu LU ,
  • Sihui LI ,
  • Xianwen LI ,
  • Mujin LI ,
  • Ju WEN
Expand
  • Department of Dermatology and Venereology，Guangdong Second Provincial General Hospital，Guangzhou 510317，Guangdong，China

Received date: 2025-01-15

  Online published: 2025-05-20

Fold

Abstract

Objective To investigate the effect of tissue-resident memory T cells （TRM） on imiquimod-induced psoriatic-like skin lesions in mice， and to elucidate the underlying mechanisms of TRM involvement in this process. Methods Forty female BALB/c mice were procured and randomly allocated into four groups： ten in the blank control group， and thirty for the establishment of a psoriasis mouse model. Following successful modeling， the thirty mice were further randomized into three groups： the model control group， the methotrexate-treated group， and the imiquimod-treated group， with ten mice in each group. Mice in the blank control group and model control group were uniformly treated with Vaseline for intervention. The methotrexate group and the imiquimod group were treated with 62.5mg of 5% imiquimod cream. The methotrexate group was administered by gavage at a dose of 1 mg/kg， and the gavage volume of each group was 10 mL/kg.The model control group， blank group and imiquimod group were gavaged with the same volume of normal saline. Treatment was conducted over six consecutive days. Subsequently， comparisons were made across groups regarding the psoriasis area and severity index （PASI）， histopathological findings， inflammatory cytokine levels， and TRM cell levels. Results （1） The imiquimod group exhibited significantly lower scores for erythema （2.54 ± 0.32）， skin thickening （2.59 ± 0.25）， and scaling （2.52 ± 0.29） compared to the methotrexate group， model control group， and blank control group （P < 0.05）. Additionally， the methotrexate group demonstrated reduced scores for erythema， skin thickening， and scaling compared to the model control group （P < 0.05）. （2）Hematoxylin-eosin （HE） staining revealed that the epidermis in the methotrexate group became thinner， with fewer parakeratotic cells and increased hair follicles. Conversely， the imiquimod group displayed abnormal cell morphology and relatively thicker white skin after modeling. （3） The imiquimod group showed significantly lower levels of TNF-α （51.63 ± 4.39 pg/mL）， IL-1β （35.53 ± 4.15 pg/mL）， IFN-γ （23.43 ± 3.41 pg/mL）， and IL-23 （15.24 ± 2.95 pg/mL） compared to the methotrexate and model control groups （P < 0.05）. Similarly， the methotrexate group exhibited reduced levels of TNF-α， IL-1β， IFN-γ， and IL-23 compared to the model control group （P < 0.05）. （4） The imiquimod group had significantly lower levels of CD8+CD103+ cells （15.39 ± 2.31） than the methotrexate and model control groups （P < 0.05）. Furthermore， the methotrexate group demonstrated lower levels of CD8+CD103+ cells compared to the model control group （P < 0.05）. Conclusion Miquimod induces heavier skin lesions， faster response， and more epidermal thickening in psoriasis like mice. CD8+ CD103+ TRM cells and inflammatory factors may be involved in the recurrence of psoriasis.

Key words： tissue-resident memory T cells; imiquimod， secondary induction; psoriasis; histopathological examination; inflammatory cytokines

Cite this article

Yuchan ZHOU , Rongchang ZHENG , Huarun LI , Jinping HUANG , Si QIN , Ting LI , Zhenyu LU , Sihui LI , Xianwen LI , Mujin LI , Ju WEN . Expression of TRM cells in the lesions of imiquimod⁃induced models of psoriasis in mice[J]. The Journal of Practical Medicine, 2025 , 41(9) : 1327 -1331 . DOI: 10.3969/j.issn.1006-5725.2025.09.008

References

1 LIU J， QU Z， CHEN H， et al. Increased levels of circulating class-switched memory B cells and plasmablasts are associated with serum immunoglobulin G in primary focal segmental glomerulosclerosis patients［J］. Int Immunopharmacol， 2021， 98（4）：107839. doi:10.1016/j.intimp.2021.107839
2 冯放， 王燕， 赵京霞， 等. 火针对咪喹莫特诱导的银屑病样小鼠皮损及STAT3通路的影响［J］. 中国针灸， 2022， 42（5）：541-548. doi:10.13703/j.0255-2930.20211112-k0005
3 SUDHA Y S， PUPPALA E R， ABUBAKAR M， et al. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways［J］. Int immunopharmacol， 2022， 103：108436. doi:10.1016/j.intimp.2021.108436
4 OH-OKA K， ABE F， SHIBUYA A， et al. CD96 Blockade Ameliorates Imiquimod Induced Psoriasis-like Dermatitis via Suppression of IL-17A Production by Dermal γδ T Cells［J］. J Immunol， 2022， 209（120）：2313-2321. doi:10.4049/jimmunol.2200502
5 马楚君， 阮彬家， 鲁人玮， 等. 芹菜素对咪喹莫特诱导的小鼠银屑病样皮损的影响及机制［J］. 临床皮肤科杂志， 2023， 52（8）：455-461.
6 RUDAISAT M AL， CHEN X， CHEN S， et al. RNA sequencing and metabolic analysis of imiquimod-induced psoriasis-like mice with chronic restrain stress［J］. Life Sci， 2023， 326：121788. doi:10.1016/j.lfs.2023.121788
7 吴敏， 刘涛峰， 刘小平， 等. 复方泽漆冲剂通过抑制NLRP3炎症小体活化改善咪喹莫特诱导银屑病样小鼠的作用及机制研究［J］. 中药新药与临床药理， 2023， 34（11）：1551-1558.
8 JIANG X， YAO Q， XIA X. Self-assembled nanoparticles with bilirubin/JPH203 alleviate imiquimod-induced psoriasis by reducing oxidative stress and suppressing Th17 expansion［J］. Chem Eng J， 2022：431P1. doi:10.1016/j.cej.2021.133956
9 郭译濛， 周明明， 郭晋荣， 等. 紫草素通过p38MAPK信号通路改善咪喹莫特诱导的小鼠银屑病样皮肤炎症反应［J］. 中国免疫学杂志， 2022， 38（6）：676-680.
10 SRIKANTH M， RASOOL M. 3， 3′-diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice［J］. Int immunopharmacol， 2022， 109：108795. doi:10.1016/j.intimp.2022.108795
11 PANDEY R， YUSUR A N， MISHRA R K， et al. Role of subnetworks mediated by TNFα， IL-23/IL-17 and IL-15 in a network involved in the pathogenesis of psoriasis［J］. Sci Rep， 2021， 11（1）：2204-2207. doi:10.1038/s41598-020-80507-7
12 孙丹， 闫小宁， 耿蒙利， 等. 银屑平片对咪喹莫特诱导银屑病样模型小鼠IL-17、IL-23、PPARγ表达的影响［J］. 中国中医药信息杂志， 2022， 29（4）：64-68.
13 FENIX K， WIJESUNDARA D K， COWIN A J， et al.Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis［J］. Int J Mol Sci， 2020， 21（19）：7228. doi:10.3390/ijms21197228
14 CHEN Y， YAN Y， LIU H， et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8 + T-cell memory in wild-type and humanized mice［J］. Theranostics， 2020， 10（23）：10466-10482. doi:10.7150/thno.45211
15 KUKULA O， K?RM?Z?KAN S， TIRYAKI ES， et al. Asiatic acid exerts an anti-psoriatic effect in the imiquimod-induced psoriasis model in mice［J］. Immunopharmacol Immunotoxicol， 2022， 44（3）：367-372. doi:10.1080/08923973.2022.2048849
16 安月鹏， 杨素清， 刘畅. 蜈蚣败毒饮对银屑病小鼠滤泡辅助性T细胞相关因子STAT3及PD-1表达的影响［J］. 中国中医药信息杂志， 2022， 29（6）：55-61.
17 WARNER S C， NAIR A， MARPADGA R， et al. IL-15 and IL15RA in Osteoarthritis： Association With Symptoms and Protease Production， but Not Structural Severity［J］. Front Immunol， 2020， 11（2）：1385-1390. doi:10.3389/fimmu.2020.01385
18 段利娜， 任裕， 景慧玲， 等. 僵蚕四草汤对咪喹莫特诱导银屑病样小鼠模型的治疗效果及机制研究［J］. 中国医药导报， 2023， 20（6）：28-32.
19 WINTER A K， WESOLOWSKI A P， MENSAH K J， et al. Revealing Measles Outbreak Risk With a Nested Immunoglobulin G Serosurvey in Madagascar［J］. Am J Epidemiol， 2018， 187（10）：2219-2226. doi:10.1093/aje/kwy114
Options
Outlines

/

〈 〉